Press Release: Histogeninc : Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering
SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Histogen Inc. (HSTO, the Company or Histogen), a drug development company for treatment of bacterial skin infections, today announced that it has filed voluntary petitions for relief under subchapter V of...
Read full article »
Histogen is a regenerative medicine company that stimulates body’s stem cells to regenerate tissues for esthetic and therapeutic markets.
Read more